Crossmark

Targeted therapies and adverse drug reactions in oncology: the role of clinical pharmacist in pharmacovigilance

Published Online: 2018-05-21

Published Print: 2018-08

Authors

Fornasier, G.

Taborelli, M.

Francescon, S.

Polesel, J.

Aliberti, M.

De Paoli, P.

Baldo, P. https://orcid.org/0000-0002-5106-7120
License Information

Text and Data Mining valid from 2018-05-21

Version of Record valid from 2018-05-21
More Information

Article History

Received: 25 May 2017

Accepted: 8 May 2018

First Online: 21 May 2018

Conflicts of interest

: None.

Document is current